A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)
Clinical trial NCT06189053 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06189053
- Sponsor
- ModernaTX, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-30
- Primary completion
- 2027-10-31
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.